|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 15-05-06 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
| 15-04-29 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Reents
PRN | Corporate Officer/Principal | 59 | - |
Dana Lee
PRN | Corporate Officer/Principal | 62 | 2013-01-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.36% | +6.27% | +3.94% | +10.48% | 50.25B | ||
| -1.02% | +0.00% | +410.72% | +609.67% | 40.39B | ||
| -0.08% | +6.32% | +26.46% | -5.24% | 34.38B | ||
| -1.05% | +7.37% | +26.96% | +61.42% | 34.4B | ||
| -4.19% | -1.84% | +3.76% | +32.17% | 26.32B | ||
| +0.31% | +0.65% | - | - | 16.64B | ||
| -3.20% | +2.51% | +70.24% | +130.50% | 16.14B | ||
| +0.93% | +1.14% | +15.03% | +22.21% | 13.71B | ||
| +0.43% | +5.69% | +100.57% | +100.57% | 13.75B | ||
| Average | -0.91% | +3.57% | +82.21% | +120.22% | 27.33B | |
| Weighted average by Cap. | -0.96% | +4.03% | +93.51% | +138.33% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















